S&P 500   4,291.55 (-1.06%)
DOW   33,722.18 (-0.84%)
QQQ   355.71 (-1.08%)
AAPL   173.06 (-1.72%)
MSFT   312.39 (-1.62%)
META   299.20 (-0.54%)
GOOGL   128.33 (-2.12%)
AMZN   127.94 (-2.54%)
TSLA   247.50 (+0.21%)
NVDA   422.76 (+0.13%)
NIO   8.51 (+1.92%)
BABA   86.20 (-1.17%)
AMD   96.20 (-1.21%)
T   15.05 (-0.07%)
F   12.54 (-0.32%)
MU   68.29 (-0.42%)
CGC   0.94 (-0.40%)
GE   110.20 (-1.36%)
DIS   80.52 (-0.60%)
AMC   8.07 (-0.86%)
PFE   32.96 (-0.06%)
PYPL   59.11 (+0.42%)
NFLX   381.67 (-0.81%)
S&P 500   4,291.55 (-1.06%)
DOW   33,722.18 (-0.84%)
QQQ   355.71 (-1.08%)
AAPL   173.06 (-1.72%)
MSFT   312.39 (-1.62%)
META   299.20 (-0.54%)
GOOGL   128.33 (-2.12%)
AMZN   127.94 (-2.54%)
TSLA   247.50 (+0.21%)
NVDA   422.76 (+0.13%)
NIO   8.51 (+1.92%)
BABA   86.20 (-1.17%)
AMD   96.20 (-1.21%)
T   15.05 (-0.07%)
F   12.54 (-0.32%)
MU   68.29 (-0.42%)
CGC   0.94 (-0.40%)
GE   110.20 (-1.36%)
DIS   80.52 (-0.60%)
AMC   8.07 (-0.86%)
PFE   32.96 (-0.06%)
PYPL   59.11 (+0.42%)
NFLX   381.67 (-0.81%)
S&P 500   4,291.55 (-1.06%)
DOW   33,722.18 (-0.84%)
QQQ   355.71 (-1.08%)
AAPL   173.06 (-1.72%)
MSFT   312.39 (-1.62%)
META   299.20 (-0.54%)
GOOGL   128.33 (-2.12%)
AMZN   127.94 (-2.54%)
TSLA   247.50 (+0.21%)
NVDA   422.76 (+0.13%)
NIO   8.51 (+1.92%)
BABA   86.20 (-1.17%)
AMD   96.20 (-1.21%)
T   15.05 (-0.07%)
F   12.54 (-0.32%)
MU   68.29 (-0.42%)
CGC   0.94 (-0.40%)
GE   110.20 (-1.36%)
DIS   80.52 (-0.60%)
AMC   8.07 (-0.86%)
PFE   32.96 (-0.06%)
PYPL   59.11 (+0.42%)
NFLX   381.67 (-0.81%)
S&P 500   4,291.55 (-1.06%)
DOW   33,722.18 (-0.84%)
QQQ   355.71 (-1.08%)
AAPL   173.06 (-1.72%)
MSFT   312.39 (-1.62%)
META   299.20 (-0.54%)
GOOGL   128.33 (-2.12%)
AMZN   127.94 (-2.54%)
TSLA   247.50 (+0.21%)
NVDA   422.76 (+0.13%)
NIO   8.51 (+1.92%)
BABA   86.20 (-1.17%)
AMD   96.20 (-1.21%)
T   15.05 (-0.07%)
F   12.54 (-0.32%)
MU   68.29 (-0.42%)
CGC   0.94 (-0.40%)
GE   110.20 (-1.36%)
DIS   80.52 (-0.60%)
AMC   8.07 (-0.86%)
PFE   32.96 (-0.06%)
PYPL   59.11 (+0.42%)
NFLX   381.67 (-0.81%)
NASDAQ:CMRA

Comera Life Sciences (CMRA) Stock Forecast, Price & News

$0.40
+0.07 (+19.76%)
(As of 12:33 PM ET)
Compare
Today's Range
$0.35
▼
$0.40
50-Day Range
$0.29
▼
$0.68
52-Week Range
$0.26
▼
$2.17
Volume
80,573 shs
Average Volume
50,286 shs
Market Capitalization
$10.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

CMRA stock logo

About Comera Life Sciences (NASDAQ:CMRA) Stock

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

CMRA Price History

CMRA Stock News Headlines

September 13, 2023 | benzinga.com
Massive Insider Trade At Comera Life Sciences
September 12, 2023 | benzinga.com
10% Owner At This Health Care Company Buys $1.05M of Stock
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
September 12, 2023 | finance.yahoo.com
Comera Life Sciences Announces the Completion of $4.1 Million Private Placement
August 16, 2023 | finance.yahoo.com
Comera Study Shows Caffeine’s Ability to Reduce Viscosity in Antibodies
August 16, 2023 | finance.yahoo.com
Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities
August 10, 2023 | finance.yahoo.com
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
August 8, 2023 | finance.yahoo.com
Comera Life Sciences Boosts SQore Platform Patents
September 26, 2023 | Micro-Cap Stock Trader (Ad)
Unlock the treasure on Mount Olympus with this little-known mining stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
August 8, 2023 | finance.yahoo.com
Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform
August 2, 2023 | finance.yahoo.com
Comera Life Sciences Announces $4.1 Million Private Placement
August 1, 2023 | finance.yahoo.com
Comera Life Sciences Announces $4.1 Million Private Placement
July 24, 2023 | finance.yahoo.com
Comera Partners with Quality Chemical Laboratories to Strengthen Supply Chain
July 15, 2023 | seekingalpha.com
CMRA Comera Life Sciences Holdings, Inc.
May 11, 2023 | finance.yahoo.com
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
May 11, 2023 | finance.yahoo.com
Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights
April 27, 2023 | finance.yahoo.com
Comera Life Sciences to Participate in Four Upcoming Conferences
April 3, 2023 | finance.yahoo.com
Comera Life Sciences Announces Expansion of Patent Portfolio Underlying Core Excipient Technology
March 16, 2023 | msn.com
Comera Life Sciences GAAP EPS of -$0.18, revenue of $0.15M
March 16, 2023 | finance.yahoo.com
Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
March 16, 2023 | finance.yahoo.com
Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights
January 31, 2023 | proactiveinvestors.com
Comera Life Sciences shares details of recent private placement
January 12, 2023 | finance.yahoo.com
Comera Life Sciences to Present at 22nd Annual PepTalk Conference
January 5, 2023 | finance.yahoo.com
Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference
January 4, 2023 | finance.yahoo.com
Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules
December 1, 2022 | uk.finance.yahoo.com
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) insiders are still down US$76k after purchasing last year, recent gain helped regain some losses
November 18, 2022 | finance.yahoo.com
Comera Life Sciences to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
See More Headlines
Receive CMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Comera Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

CMRA Company Calendar

Last Earnings
8/10/2023
Today
9/26/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CMRA
CUSIP
N/A
CIK
1907685
Web
comeralifesciences.com
Phone
617-871-2101
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-18,000,000.00
Net Margins
-906.55%
Pretax Margin
-903.82%
Return on Equity
N/A
Return on Assets
-284.60%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.46
Quick Ratio
0.46

Sales & Book Value

Annual Sales
$630,000.00
Price / Sales
14.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.37) per share
Price / Book
-0.90

Miscellaneous

Outstanding Shares
27,180,000
Free Float
24,757,000
Market Cap
$9.08 million
Optionable
Not Optionable
Beta
1.04
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Jeffrey S. Hackman (Age 63)
    Chairman, Pres & CEO
    Comp: $400k
  • Mr. Michael G. Campbell CPA (Age 54)
    Exec. VP & CFO
    Comp: $269.11k
  • Dr. Neal I. Muni M.D. (Age 48)
    MSPH, Exec. VP & COO
    Comp: $350k
  • Dr. David Soane Ph.D.
    Co-Founder & Member of Scientific Advisory Board
  • Dr. Robert P. Mahoney Ph.D. (Age 59)
    Chief Scientific Officer
  • Ms. Janice Marie McCourt B.S. (Age 61)
    CLP, M.B.A., R.Ph., Chief Bus. Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













CMRA Stock - Frequently Asked Questions

How have CMRA shares performed in 2023?

Comera Life Sciences' stock was trading at $1.23 at the start of the year. Since then, CMRA shares have decreased by 72.8% and is now trading at $0.3340.
View the best growth stocks for 2023 here.

Are investors shorting Comera Life Sciences?

Comera Life Sciences saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 6,100 shares, a decline of 67.2% from the August 15th total of 18,600 shares. Based on an average daily trading volume, of 69,300 shares, the days-to-cover ratio is presently 0.1 days. Approximately 1.3% of the company's shares are sold short.
View Comera Life Sciences' Short Interest.

When is Comera Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our CMRA earnings forecast.

How were Comera Life Sciences' earnings last quarter?

Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) released its quarterly earnings results on Thursday, August, 10th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company earned $0.32 million during the quarter.

What is Comera Life Sciences' stock symbol?

Comera Life Sciences trades on the NASDAQ under the ticker symbol "CMRA."

How do I buy shares of Comera Life Sciences?

Shares of CMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Comera Life Sciences' stock price today?

One share of CMRA stock can currently be purchased for approximately $0.33.

How much money does Comera Life Sciences make?

Comera Life Sciences (NASDAQ:CMRA) has a market capitalization of $9.08 million and generates $630,000.00 in revenue each year. The company earns $-18,000,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis.

How can I contact Comera Life Sciences?

Comera Life Sciences' mailing address is 1395 BRICKELL AVENUE SUITE 800, MIAMI FL, 33131. The official website for the company is comeralifesciences.com. The company can be reached via phone at 617-871-2101 or via email at john.woolford@westwicke.com.

This page (NASDAQ:CMRA) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -